Series B startup

Who invested in Health Scholars

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$17Mraised across 1 round since 2020, from 1 source

Latest round
Series B, $17MJan 2020
Investors
1
See who backed them

The rounds

  1. Jan 2020
    Series B$17M

    Source recordedSEC filing: $7.6M sold, first sale Dec 2019

Founders and team

From the SEC filings it signed: 4 on the team.

  • Angela McfarlandExecutive Officeri
  • Brian GillettExecutive Officeri
  • Laura MedinaExecutive Officeri
  • Scott JohnsonExecutive Officer, Directori

On the board, as filediAlvin VitangcolJohn NeisKristen ValdesRikard SteiberRobert SehringThomas Shehab

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Health Scholars as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Capital MidwestVC firmPer its own site

Quick answers about Health Scholars

Who invested in Health Scholars?

Health Scholars's investors include Service Provider Capital.

How much has Health Scholars raised?

Health Scholars has raised $17M across 1 round since 2020.

When did Health Scholars last raise?

Health Scholars's most recent round was a Series B of $17M in Jan 2020.

What was Health Scholars's biggest round?

Its most recent round, $17M in Jan 2020, is also its largest on record.

Who backed Health Scholars first?

Health Scholars's first round on record, in Jan 2020, was backed by Service Provider Capital.

What stage is Health Scholars at?

Health Scholars's latest named round is a Series B, in Jan 2020.

Companies like Health Scholars

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.